eDNA: A dual nongenetic gamechanger in biofilm development and depletion
Microbial Pathogenesis · 2026-08 · 217 · 108612
DOI: 10.1016/j.micpath.2026.108612 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2026-08. Verfasst von Raghda Elawady und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Medical Research Institute, Alexandria University, Alexandria, Egypt. Electronic address: mri.raghda.m.microbiology18@ale…. Hauptthemen laut MEDLINE: Biofilms, Extrachromosomal DNA, Bacteria, DNA, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 155 Literaturangaben.
Abstract (Originalsprache)
Biofilms, first described by Anthony van Leeuwenhoek (1632-1723), are surface-attached, organized microbial communities. They form when single cells embed within an extracellular matrix (ECM) composed mainly of extracellular polymeric substances (EPS), enabling a multicellular lifestyle. Extracellular DNA (eDNA), a major EPS component, makes up a substantial portion of biofilm biomass. It interacts with polysaccharides, proteins, and nucleic acids to create a stable network that reinforces biofilm structure. eDNA, present in all biofilm ECM, plays a paradoxical role in bacterial survival. It is vital for structural integrity, guiding the biofilm from initial attachment through maturation and dispersion, yet this dependence also creates a critical vulnerability. Recent research highlights that while eDNA supports biofilm growth, disrupting its release, interactions, or structure destabilizes the matrix and drives depletion. Recognizing eDNA as both a structural scaffold and a therapeutic target enables more effective strategies to inhibit and disperse resilient biofilm communities. This review highlights recent advances in eDNA-releasing mechanisms, its multifunctional roles in biofilm support, and how its structures and interactions regulate development. We further show that modulating eDNA provides a targeted strategy for antibiofilm therapy and clinical dispersal. Notably, eDNA itself may also act as a cue for biofilm inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Medical Research Institute, Alexandria University, Alexandria, Egypt. Electronic address: mri.raghda.m.microbiology18@alexu.edu.eg.
- Department of Microbiology, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Zitieren
APA
Elawady, R., & Gaballah, A. (2026). eDNA: A dual nongenetic gamechanger in biofilm development and depletion. Microbial Pathogenesis, 217, 108612. https://doi.org/10.1016/j.micpath.2026.108612
Vancouver
Elawady R, Gaballah A. eDNA: A dual nongenetic gamechanger in biofilm development and depletion. Microbial Pathogenesis. 2026;217:108612. doi:10.1016/j.micpath.2026.108612
BibTeX
@article{Elawady2026,
author = {Elawady, Raghda and Gaballah, Ahmed},
title = {eDNA: A dual nongenetic gamechanger in biofilm development and depletion},
journal = {Microbial Pathogenesis},
year = {2026},
volume = {217},
pages = {108612},
doi = {10.1016/j.micpath.2026.108612}
}
EUVIMED